Event

Klaus F. Rabe

Pulmonary Medicine
LungClinic Grosshansdorf;LungenClinic Grosshansdorf;LungenClinic Grosshansdorf and Christian Albrechts University;LungenClinic Grosshansdorf and Christian-Albrechts University, Kiel, Airway Research C

Kerstine Carter

MBiostat
Boehringer Ingelheim Corporation;Boehringer Ingelheim Pharmaceuticals, Inc.

Antonio Anzueto

MD
South Texas Veterans Health Care System and University of Texas;Univ of Texas Hlth Sci Ctr at San Antonio;University of Texas Health – Medicine San Antonio;University of Texas Health Sciences Center a

Jadwiga A. Wedzicha

MD, PhD
Imperial College London;National Heart and Lung Institute;National Heart and Lung Institute, Imperial College London

Christine Jenkins

MD, FRACP
The George Institute for Global Health

Lars Grönke

MD
Boehringer Ingelheim Pharma GmbH & Co. KG

Peter M. Calverley

DSc, F MedSci
Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool;Institute of Ageing and Chronic Disease, University of Liverpool;University of Liverpool;University of Liverpo

Christoph Hallmann

MD
Boehringer Ingelheim Pharma GmbH & Co. KG

Tiotropium/Olodaterol in the Prevention of Chronic Obstructive Pulmonary Disease Exacerbations: Results from the DYNAGITO Trial